C07K 14/8135
Kazal type inhibitors
Official title: {Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid}
C07K14/8135 (Kazal type inhibitors) appears on 71 US grants and 100 published applications in this corpus.
Search patents in C07K- Granted patents
- 71
- Published applications
- 100
- Assignees
- 31
- Inventors
- 157
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 1 | 3 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 1 | 3 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 13 |
| 2018 | 8 | 2 |
| 2019 | 6 | 10 |
| 2020 | 5 | 8 |
| 2021 | 5 | 14 |
| 2022 | 6 | 17 |
| 2023 | 6 | 5 |
| 2024 | 8 | 13 |
| 2025 | 7 | 3 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Expression of the human lekti gene from the chromosome of Staphylococcus epidermidis29 Sep 2026US 12,747,281 B2Azitra Inc
- Method of improving blood kinetics of peptide30 Jun 2026US 12,668,619 B2Dalichi Sankyo Company, Limited
- Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes21 Apr 2026US 12,606,610 B2Azitra Inc
- Protein compositions and consumable products thereof6 May 2025US 12,290,088 B2Clara Foods Co.
- Peptides and combination of peptides for use in immunotherapy against various cancers18 Feb 2025US 12,226,467 B2Immatics Biotechnologies GmbH
- Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes9 Jul 2026US 2026/0193323 A1Azitra Inc
- Protein compositions and consumable products thereof14 Aug 2025US 2025/0255328 A1Clara Foods Co.
- Protein compositions and consumable products thereof3 Jul 2025US 2025/0215049 A1Clara Foods Co.
- Novel t cell receptors and immune therapy using the same15 May 2025US 2025/0154246 A1Immatics Biotechnologies GmbH
- Klk5 inhibitory peptide31 Oct 2024US 2024/0360200 A1Daiichi Sankyo Company, Limited
Most cited
By later US patents
- Inhibitors of urokinase plasminogen activator44US 5,550,213 ARutgers, The State University of New Jersey · 1996
- Therapeutic application of Kazal-type serine protease inhibitors31US 8,283,319 B2CSL Behring GmbH · 2012
- Ovomucoid promoter and methods of use17US 6,875,588 B2AviGenics, Inc. · 2005
- Peptides and combination of peptides for use in immunotherapy against various cancers16US 10,058,598 B2Immatics Biotechnologies GmbH · 2018
- Peptides and combination of peptides for use in immunotherapy against various cancers16US 10,098,938 B2Immatics Biotechnologies GmbH · 2018